Paul E. Oberstein, MD, discusses data for an autogene cevumeran–based regimen in pancreatic ductal adenocarcinoma.
Back
Exploring RNA Neoantigen Vaccines in Pancreatic Cancer
Paul E. Oberstein, MD, breaks down research for the mRNA vaccine autogene cevumeran in pancreatic cancer.
Exploring RNA Neoantigen Vaccines in Pancreatic Cancer
Episodes
All
All
Advertisement
Advertisement
Trending on OncLive
1
FDA Issues CRL to 177Lu-Edotreotide for GEP-NETs
2
SYNC-T Therapy SV-102 Shows Early Promise, Advances to Phase 2 LEGION-100 Trial in Refractory Prostate Cancer
3
Sonrotoclax Is Active in Chinese R/R MCL Cohort of the BGB-11417-201 Trial
4
Five Under 5: Top Oncology Videos for the Week of 8/2
5